menu search

Theriva biologics jumps on us fda approval for pancreatic cancer treatment

Theriva Biologics Inc saw its shares surge over 70% higher in after-hours US trading following news that its lead clinical ...

June 28, 2023, 8:51 am

Eli lilly stock nabs record on obesity drug trial data

Eli Lilly And Co (NYSE:LLY) released mid-stage trial data earlier today showing its obesity drug candid...

June 27, 2023, 11:08 am

Lobe sciences commences phase 1 clinical study to evaluate l-130

Lobe Sciences Ltd (CSE:LOBE, OTCQB:LOBED) said it has commenced a Phase 1 clinical study to evaluate L-130, their proprietary stabilized psilocin anal...

June 27, 2023, 8:16 am

Ac immune's stock soars 13% after fda grants fast-track designation to alzheimer's treatment

AC Immune SA's stock ACIU, +4.21% soared 13% premarket Tuesday, after the Swiss-based biotech said it has received U.S. Food and Drug Administration f...

June 27, 2023, 7:52 am

Gsk's gonorrhoea vaccine receives fda's 'fast-track' designation

GSK's vaccine candidate to treat sexually transmitted infection gonorrhoea has been granted a fast-trac...

June 27, 2023, 3:15 am

Why viking therapeutics stock is crashing today

A top competitor announced plans to move forward with a late-stage weight loss candidate today. Viking'...

June 26, 2023, 11:39 pm

Pfizer stock drops after company picks twice-daily weight loss pill candidate

Yahoo Finance reporter Anjalee Khemlani reports the latest news on Pfizer weight loss drugs....

June 26, 2023, 5:44 pm

Lilly experimental 'triple g' obesity drug leads to 24.2% weight loss in trial -nejm

Eli Lilly's mid-stage trial of its next-generation "triple g" obesity drug candidate found that the hig...

June 26, 2023, 5:43 pm

Arcturus therapeutics: a beacon of hope for rare diseases amid the mrna race

Arcturus Therapeutics is developing mRNA medicines and vaccines for infectious diseases and rare disorders, with a focus on their ARCT-810 ...

June 26, 2023, 1:40 pm

Abbvie (abbv) gets chmp positive opinion for atogepant approval

AbbVie (ABBV) receives a positive recommendation from the European Union's medicinal products committee for the approval of its migraine treatment ...

June 26, 2023, 12:46 pm

Amylyx (amlx) down on negative chmp opinion for als candidate

Amylyx's (AMLX) shares plunge on getting a negative opinion from the Committee for Medicinal Products for Human Use for the marketing authorization of...

June 26, 2023, 12:01 pm

Why pfizer stock is tanking today

Pfizer is discontinuing the development of an early-stage weight loss candidate over safety concerns. A...

June 26, 2023, 11:20 am

Mercury systems to focus on enhanced execution of strategic plan under refreshed leadership team

Board Concludes Thorough Review of Strategic Alternatives; Remains Open to All Pathways to Maximize Shareholder Value Board Appoints Bill Ballhaus Int...

June 23, 2023, 8:05 pm

Pieris (pirs) declines as azn halts study of asthma candidate

Pieris' (PIRS) shares nosedive as its partner decides to discontinue a phase IIa study evaluating elarekibep for treating asthma, based on non-clinica...

June 23, 2023, 11:54 am

In one chart: here are the republicans running for president as former texas rep. will hurd enters the 2024 race

This is MarketWatch’s list of the 2024 Republican presidential contenders and the status of their candid...

June 22, 2023, 5:38 pm

Transcode therapeutics announces publication of new data supporting the use of ttx-mc138 for the treatment of metastatic breast cancer

BOSTON, June 22, 2023 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treatin...

June 22, 2023, 11:00 am

Sarepta therapeutics: value proposition ahead of dmd gene therapy decision

Sarepta Therapeutics should earn ~$1bn from its Duchenne Muscular Dystrophy franchise in 2023 - although the company has made eye-watering losses in r...

June 22, 2023, 8:45 am

: activist investor elliott management reportedly seeks to oust nrg energy’s ceo

According to the Wall Street Journal, Elliott is talking with potential candidates to replace Chief Exe...

June 21, 2023, 11:57 pm

Catalyst (cprx) to gain dmd drug licensing rights from santhera

Catalyst (CPRX) announces entering into a definitive agreement to acquire licensing rights in North America to Santhera's DMD treatment ...

June 21, 2023, 10:19 am

Is crispr therapeutics stock a buy now?

CRISPR Therapeutics expects a regulatory decision on its first potential product later this year. The blood disorders ...

June 21, 2023, 5:30 am


Search within

Pages Search Results: